Cargando…
Targeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model
BACKGROUND: Cytotoxic chemotherapy can be very effective for the treatment of cancer but toxicity on normal tissues often limits patient tolerance and often causes long-term adverse effects. The objective of this study was to assist in the preclinical development of using modified, non-living bacter...
Autores principales: | MacDiarmid, Jennifer A., Langova, Veronika, Bailey, Dale, Pattison, Scott T., Pattison, Stacey L., Christensen, Neil, Armstrong, Luke R., Brahmbhatt, Vatsala N., Smolarczyk, Katarzyna, Harrison, Matthew T., Costa, Marylia, Mugridge, Nancy B., Sedliarou, Ilya, Grimes, Nicholas A., Kiss, Debra L., Stillman, Bruce, Hann, Christine L., Gallia, Gary L., Graham, Robert M., Brahmbhatt, Himanshu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822833/ https://www.ncbi.nlm.nih.gov/pubmed/27050167 http://dx.doi.org/10.1371/journal.pone.0151832 |
Ejemplares similares
-
Bacterial minicells to the rescue: cyto‐Immunotherapy for the treatment of late stage cancers with minimal to no toxicity
por: Brahmbhatt, Himanshu, et al.
Publicado: (2021) -
A First-Time-In-Human Phase I Clinical Trial of Bispecific Antibody-Targeted, Paclitaxel-Packaged Bacterial Minicells
por: Solomon, Benjamin J., et al.
Publicado: (2015) -
Nanocell targeting using engineered bispecific antibodies
por: Taylor, Karin, et al.
Publicado: (2014) -
Translational applications of microRNAs in cancer, and therapeutic implications
por: Kwok, Grace T., et al.
Publicado: (2017) -
Nanocell-mediated delivery of miR-34a counteracts temozolomide resistance in glioblastoma
por: Khan, Muhammad Babar, et al.
Publicado: (2021)